Vitaprost P / o enteric tablets, 20 mg, # 20

Tablets from blue to light blue, round, biconvex, inclusions are allowed.

Pharmaco-therapeutic group

N4 Chronic abacterial prostatitis.

Prevention of exacerbations of chronic abacterial prostatitis.

Benign prostatic hyperplasia.

Conditions before and after surgery on the prostate gland.

Application during pregnancy and during breastfeeding

Dosage form

Enteric-coated tablets, 20 mg.

On 10 tablets in a blister strip of a film of polyvinyl chloride or polyvinyl chloride / polyvinylidene chloride and printed aluminum foil varnished.

1, 2 or 3 blisters together with instructions for medical use of the medicinal product in a cardboard box

Shelf life

3 years.

Do not use the drug after the expiration date.

Category

Urology

Name ENG

VITAPROST

Clinical and pharmacological group

An animal drug used for diseases of the prostate gland

ATX code

Other drugs for the treatment of urological diseases

Dosage

20mg

Structure

One tablet contains: active substance: prostate extract - 100 mg (in terms of water-soluble peptides - 20 mg) excipients: sucrose - 28.500 mg, lactose monohydrate - 7.125 mg, calcium stearate monohydrate - 2.500 mg, crospovidone - 9.275 mg, cellulose microcrystalline - up to 102,600 mg shell composition: acrylic (methacrylic acid and ethyl acrylate copolymer [1: 1], titanium dioxide, talc, triethyl citrate, colloidal silicon dioxide, sodium bicarbonate, sodium lauryl sulfate, indigocarmine) - 25 mg.

Indications

Chronic abacterial prostatitis.

Prevention of exacerbations of chronic abacterial prostatitis.

Benign prostatic hyperplasia.

Conditions before and after surgery on the prostate gland.

INN / Active ingredient

Prostate extract

Contraindications

Hypersensitivity to drug components.

Lactase deficiency, sucrase / isomaltase deficiency, lactose intolerance, fructose intolerance, glucose-galactose malabsorption (the drug contains lactose and sucrose).

Storage conditions and periods

At a temperature not higher than 25 ° C.

Keep out of the reach of children.

Specifications

Category

BPH

,

Impotence in men

Scope of the medicinal product

Genitourinary system

Release form

Tablet

Manufacturer country

Russia

Package quantity, pcs

twenty

Scope of application

Urology

Vacation conditions

Without recipe

Brand name

Vitaprost

The amount of the dosage form in the primary package

10 pieces.

Primary packaging type

Blister

Type of consumer packaging

Pack of cardboard

Pharmaco-therapeutic group

Chronic prostatitis treatment

Anatomical and therapeutic characteristics

G04BX Drugs for the treatment of urological diseases other

Dosage form

Enteric-coated tablets

Packaging

Box

The target audience

Adult

Expiration date in days

1095

Package weight, g

3

Mode of application

:

Inside, 1 tablet 2 times a day.

The duration of the course of treatment with Vitaprost® for benign prostatic hyperplasia is at least 30 days, for chronic prostatitis - at least 10 days.

For the prevention of exacerbations of chronic prostatitis, 1 tablet is used 2 times a day for at least 30 days - 1-2 times a year.

Dosage (volume) of the substance in the preparation

:

1 tablet: prostate extract 100 mg (in terms of water-soluble peptides 20 mg)